Atazanavir—highlights from the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Rome, 17–20 July 2011.
In: HIV & AIDS Review, Jg. 10 (2011-12-01), Heft 4, S. 82-86
academicJournal
Zugriff:
Abstract: The International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention is the world''s largest annual conference on HIV/AIDS. Some 5000 international scientists, clinicians, public health experts and community leaders gathered in Rome, Italy between the 17 and 20 July, 2011 to learn and share the latest findings in HIV-related research. Salient topics addressed at the conference included the effectiveness of various antiretroviral treatment (ART), including atazanavir/ritonavir-, darunavir/ritonavir-, raltegravir-, and maraviroc- based regimens, as well as the potential adverse effects of these ART therapies, particularly in terms of their effect on the cardiac and renal systems. This paper highlights some of the most exciting findings presented. [Copyright &y& Elsevier]
Copyright of HIV & AIDS Review is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Atazanavir—highlights from the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Rome, 17–20 July 2011.
|
---|---|
Autor/in / Beteiligte Person: | Mikuła, Tomasz ; Stańczak, Wojciech |
Zeitschrift: | HIV & AIDS Review, Jg. 10 (2011-12-01), Heft 4, S. 82-86 |
Veröffentlichung: | 2011 |
Medientyp: | academicJournal |
ISSN: | 1730-1270 (print) |
DOI: | 10.1016/j.hivar.2011.10.001 |
Schlagwort: |
|
Sonstiges: |
|